Eudaimonia Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,507
Closed -$323K 349
2023
Q3
$323K Sell
2,507
-322
-11% -$42.8K 0.08% 223
2023
Q2
$375K Sell
2,829
-406
-13% -$53.5K 0.08% 223
2023
Q1
$419K Sell
3,235
-84
-3% -$11K 0.1% 204
2022
Q4
$451K Sell
3,319
-15
-0.4% -$1.99K 0.11% 188
2022
Q3
$404K Buy
3,334
+706
+27% +$90.9K 0.11% 189
2022
Q2
$337K Buy
2,628
+18
+0.7% +$2.36K 0.06% 279
2022
Q1
$358K Buy
+2,610
New +$346K 0.06% 294
2021
Q3
$274K Buy
2,154
+36
+2% +$4.76K 0.05% 319
2021
Q2
$267K Buy
2,118
+185
+10% +$22.7K 0.05% 323
2021
Q1
$226K Buy
1,933
+56
+3% +$6.46K 0.05% 312
2020
Q4
$213K Sell
1,877
-34
-2% -$3.71K 0.05% 301
2020
Q3
$202K Buy
1,911
+308
+19% +$32.4K 0.05% 288
2020
Q2
$160K Buy
1,603
+384
+32% +$37.9K 0.06% 269
2020
Q1
$108K Buy
+1,219
New +$118K 0.05% 319

Other funds holding XLV

Eudaimonia Partners's XLV Position: Q4 2023 in Review

Eudaimonia Partners sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2023, closing a stake of 2,507 shares — an estimated $323K sold.

Eudaimonia Partners first reported a position in XLV in Q1 2020 and held it in 14 quarters. The position peaked at $451K in Q4 2022. 1,641 funds tracked by Wall St. Rank hold XLV as of Q4 2023.

  • Eudaimonia Partners reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2023 after selling out during the quarter.
  • Eudaimonia Partners sold 2,507 State Street Health Care Select Sector SPDR ETF shares in Q4 2023, an estimated $323K.
  • Eudaimonia Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2020 and held it in 14 quarters.
  • Eudaimonia Partners's State Street Health Care Select Sector SPDR ETF position peaked at $451K in Q4 2022.
  • 1,641 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2023.

Based on Eudaimonia Partners's 13F filing for Q4 2023, filed 8 Feb 2024.